Alchemab Therapeutics vs Janux Therapeutics
Alchemab Therapeutics vs Janux Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alchemab Therapeutics is on 42/100 and Janux Therapeutics on 57/100.
Where each one leads
Alchemab Therapeutics
Leads on none of the measures we hold for both companies.
Janux Therapeutics
- our overall score: 57/100 against 42/100
- agent readiness: 42/100 against 36/100
- domain rating: 39/100 against 33/100
- funding raised: $181M against $31.5M
At a glance
| Measure | Alchemab Therapeutics | Janux Therapeutics |
|---|---|---|
| What it is | Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals. | A clinical-stage biopharmaceutical company developing novel immunotherapies. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2017 |
| Headquarters | London, United Kingdom | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Alchemab Therapeutics | Janux Therapeutics |
|---|---|---|
| Employees | Not published | 110 |
| Total funding | $31.5M | $181M |
| Latest round | Series A | Series B |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 12,449 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alchemab Therapeutics | Janux Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 57/100 |
| Traction | 37/100 | 60/100 |
| Team | Not published | 30/100 |
| Search visibility | 8/100 | 35/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alchemab Therapeutics | Janux Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
Alchemab Therapeutics vs Janux Therapeutics: common questions
Which is better, Alchemab Therapeutics or Janux Therapeutics?
On our 0-100 score Janux Therapeutics rates higher (57/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Alchemab Therapeutics and Janux Therapeutics compare on the numbers?
Janux Therapeutics leads on our overall score (57/100 against 42/100), agent readiness (42/100 against 36/100), domain rating (39/100 against 33/100), funding raised ($181M against $31.5M).
Read the full Alchemab Therapeutics review and pricing or the Janux Therapeutics review and pricing. You can also browse other Alchemab Therapeutics alternatives we track.